Market TodayThemes and Stocks SummaryThematic Stock SearchDaily Refresh Schedule
OVID - Ovid Therapeutics Inc
-0.05(-1.24%)9:00:01 PM 3/5/2021
Ovid Therapeutics Inc., a biopharmaceutical company, develops impactful medicines for patients and families with neurological disorders in the United States. The company is developing OV101, a drug candidate, which is in Phase III clinical trial for the treatment of angelman syndrome in adults; and completed Phase II clinical trial for the treatment of fragile X syndrome in adolescent and young male adults. It is also developing OV935, a drug candidate, which is in a Phase II clinical trial for the treatment of cyclin-dependent kinase-like 5 deficiency disorder and dravet syndrome. In addition, the company undertakes research programs exploring OV329 in infantile spasm/rare epilepsies; and OV881 as a microRNA gene therapy for the treatment of angelman syndrome. Ovid Therapeutics Inc. has a collaboration agreement with Takeda Pharmaceutical Company Limited; a license agreement with H. Lundbeck A/S; strategic research collaboration with Columbia University Irving Medical Center; and license agreement with Angelini Pharma to develop, manufacture and commercialize OV101 for the treatment of angelman syndrome in Europe. The company was founded in 2014 and is headquartered in New York, New York.
Stock Chart

Short Volume Ratio = Short Volume / All Volume. Source of Short Volume data comes from 


Moving Average Convergence/Divergence oscillator (MACD) is one of the simplest and most effective momentum indicators available.

Relative Strength Index (RSI) is a momentum oscillator that measures the speed and change of price movements. RSI oscillates between zero and 100. According to Wilder, RSI is considered overbought when above 70 and oversold when below 30.


  • Volatility is at a recent 2 week high. A high volatility of stock movement indicates uncertainty.
Stock Statistics
PE Ratio
PEG Ratio
P/S (ttm)27.1
Earning Growth (QoQ)
Revenue Growth (QoQ)
Short %6%
Held by Institutions %40%
1 Day Vol Adjusted Return-0.1
1 Month Vol Adjusted Return2.1
3 Month Vol Adjusted Return5.4
6 Month Vol Adjusted Return-4.6
20 Days SMA Price ZScore1.6
50 Days SMA Price ZScore2.2
12 -26 Days PPO5.2
1 Month Average Short Volume Ratio42.8
1 Day Volume Change ZScore-0.1
1 Month Daily Vol9.7
Related Topics
leak data

Related Topics


Related Peers

Stock news